Literature DB >> 19074977

An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia.

Bruce I Turetsky1, Paul J Moberg.   

Abstract

OBJECTIVE: Although olfactory deficits are common in schizophrenia, their underlying pathophysiology remains unknown. Recent evidence has suggested that cAMP signaling may be disrupted in schizophrenia. Since cAMP mediates signal transduction in olfactory receptor neurons, this could contribute to the etiology of observed olfactory deficits. This study was designed to test this hypothesis by determining odor detection threshold sensitivities to two odorants that differ in their relative activations of this intracellular cAMP signaling cascade.
METHOD: Thirty schizophrenia patients, 25 healthy comparison subjects, and 19 unaffected first-degree relatives of schizophrenia patients were studied. Odor detection threshold sensitivities were measured for the two odorants citralva and lyral. Although both have fruity/floral scents, citralva strongly activates adenylyl cyclase to increase cAMP levels, while lyral is a very weak activator of adenylyl cyclase.
RESULTS: There was a significant group-by-odor interaction. Both schizophrenia patients and unaffected first-degree relatives were impaired in their ability to detect lyral versus citralva. Comparison subjects were equally sensitive to both odorants. This selective deficit could not be explained by differences in age, sex, smoking, clinical symptom profile, or medication use.
CONCLUSIONS: This study establishes the presence of an odor-specific hyposmia that may denote a disruption of cAMP-mediated signal transduction in schizophrenia. The presence of a parallel deficit in the patients' unaffected first-degree relatives suggests that this deficit is genetically mediated. Although additional physiological studies are needed to confirm the underlying mechanism, these results offer strong inferential support for the hypothesis that cAMP signaling is dysregulated in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074977      PMCID: PMC3524831          DOI: 10.1176/appi.ajp.2008.07071210

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  31 in total

Review 1.  G protein pathways.

Authors:  Susana R Neves; Prahlad T Ram; Ravi Iyengar
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  Odors detected by mice deficient in cyclic nucleotide-gated channel subunit A2 stimulate the main olfactory system.

Authors:  Weihong Lin; Julie Arellano; Burton Slotnick; Diego Restrepo
Journal:  J Neurosci       Date:  2004-04-07       Impact factor: 6.167

3.  An assessment of olfactory deficits in patients with damage to prefrontal cortex.

Authors:  H Potter; N Butters
Journal:  Neuropsychologia       Date:  1980       Impact factor: 3.139

4.  Reduced olfactory bulb volume in patients with schizophrenia.

Authors:  B I Turetsky; P J Moberg; D M Yousem; R L Doty; S E Arnold; R E Gur
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

5.  Impaired olfactory identification in relatives of patients with familial schizophrenia.

Authors:  L C Kopala; K P Good; K Morrison; A S Bassett; M Alda; W G Honer
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

6.  Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia.

Authors:  Warrick J Brewer; Stephen J Wood; Patrick D McGorry; Shona M Francey; Lisa J Phillips; Alison R Yung; Vicki Anderson; David L Copolov; Bruce Singh; Dennis Velakoulis; Christos Pantelis
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

7.  The odorant-sensitive adenylate cyclase of olfactory receptor cells. Differential stimulation by distinct classes of odorants.

Authors:  P B Sklar; R R Anholt; S H Snyder
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

8.  cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction.

Authors:  R I Henkin; I Velicu
Journal:  Clin Invest Med       Date:  2008       Impact factor: 0.825

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  Cross-adaptation between olfactory responses induced by two subgroups of odorant molecules.

Authors:  Hiroko Takeuchi; Yukie Imanaka; Junzo Hirono; Takashi Kurahashi
Journal:  J Gen Physiol       Date:  2003-09       Impact factor: 4.086

View more
  23 in total

1.  Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis.

Authors:  Vidyulata Kamath; Bruce I Turetsky; Monica E Calkins; Christian G Kohler; Catherine G Conroy; Karin Borgmann-Winter; Dana E Gatto; Raquel E Gur; Paul J Moberg
Journal:  World J Biol Psychiatry       Date:  2011-11-10       Impact factor: 4.132

2.  An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis.

Authors:  Vidyulata Kamath; Paul J Moberg; Monica E Calkins; Karin Borgmann-Winter; Catherine G Conroy; Raquel E Gur; Christian G Kohler; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2012-04-25       Impact factor: 4.939

Review 3.  Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research.

Authors:  Joëlle Lavoie; Akira Sawa; Koko Ishizuka
Journal:  Curr Opin Psychiatry       Date:  2017-05       Impact factor: 4.741

4.  Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.

Authors:  J D Woolley; O Lam; B Chuang; J M Ford; D H Mathalon; S Vinogradov
Journal:  Psychoneuroendocrinology       Date:  2015-01-07       Impact factor: 4.905

Review 5.  A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

Authors:  Michy P Kelly
Journal:  Adv Neurobiol       Date:  2017

6.  Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia.

Authors:  Karin E Borgmann-Winter; Hoau-Yan Wang; Rabindranath Ray; Brooke R Willis; Paul J Moberg; Nancy E Rawson; Raquel E Gur; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Bull       Date:  2015-09-15       Impact factor: 9.306

7.  Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

Authors:  Mary R Lee; Heidi J Wehring; Robert P McMahon; Jared Linthicum; Nicola Cascella; Fang Liu; Alan Bellack; Robert W Buchanan; Gregory P Strauss; Carlo Contoreggi; Deanna L Kelly
Journal:  Schizophr Res       Date:  2013-02-13       Impact factor: 4.939

8.  Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification test.

Authors:  Koko Ishizuka; Katsunori Tajinda; Carlo Colantuoni; Masahiko Morita; Jessica Winicki; Cindy Le; Sandra Lin; David Schretlen; Akira Sawa; Nicola G Cascella
Journal:  Neurosci Res       Date:  2009-10-09       Impact factor: 3.304

9.  PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain.

Authors:  Shweta Hegde; Hao Ji; David Oliver; Neema S Patel; Nicolas Poupore; Michael Shtutman; Michy P Kelly
Journal:  Neuroscience       Date:  2016-08-17       Impact factor: 3.590

10.  Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; Paul J Moberg; James J Yi; Andrew S Wiemken; Erich M Dress; Tyler M Moore; Monica E Calkins; Donna M McDonald-McGinn; Elaine H Zackai; Beverly S Emanuel; Ruben C Gur; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2018-07-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.